VentriPoint Diagnostics Ltd.VPT - TSX Venture
Shares issued: 68.8 million
Fully diluted: 83.7 million
------------------------------------------------------------------------------
It was announced this morning that VentriPoint Diagnostics is using Bloom Burton & Co. to raise up to $3 million.
The unit offering consists of one common share set at $0.17 and one half of one common share purchase warrant. Each whole warrant will entitle the holder to acquire one additional common share at $0.25 for a period of 36 months.
Proceeds of the private placement will be used for the following: (i) expenditures with respect to product and service commercialization of the VentriPoint Medical System ("VMS"); (ii) expansion of VMS functionality, including applications for additional diagnoses and heart diseases; and (iii) for working capital.
If you would like to know more about this placement, please click here to send us your contact information and we will forward the request to the appropriate member of VentriPoint management.
To view the news release, please click here
0 comments:
Post a Comment